Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess if 10 mg BAY 59-7939, taken once daily as a tablet, is safe and can help prevent blood clots forming after a hip replacement operation.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bayer
NCT06596044 · Suicide Prevention
NCT07509853 · HIV Prevention, Substance Use, and more
NCT07512869 · HIV Prevention, Substance Use, and more
NCT07349940 · Skin Cancer Prevention, Melanoma In Situ, and more
NCT05373940 · Heart Failure, Primary Prevention of Sudden Cardiac Death, and more
Birmingham, Alabama
Denver, Colorado
Bay Pines, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions